-
1
Mayor Isko has enough antibodies vs severe COVID-19 after 2nd dose of CoronaVac
Yayımlandı Manila Bulletin (2021)Makale -
2
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 2 biopharmaceutical characterization: the NISTmAb case study
Baskı/Yayın Bilgisi 2015Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource
-
3
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 3 defining the next generation of analytical and biophysical techniques
Baskı/Yayın Bilgisi 2015Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
4
State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization
Baskı/Yayın Bilgisi 2014Available for University of the Philippines Diliman via ACS Publications. Click here to access
Also available remotely for University of the Philippines Diliman via ACS Publications. Click here to access thru EZproxy
Electronic Resource -
5
Antibody expression and production
Yayımlandı Springer eBooks. (2011)Available for University of the Philippines Diliman via SpringerLink. Click here to access
Electronic Resource -
6
Bispecific antibodies
Yayımlandı Springer ebooks. (2011)Available for University of the Philippines Diliman via SpringerLink. Click here to access
Electronic Resource -
7
Handbook of therapeutic antibodies technologies, emerging developments and approved therapeutics
Baskı/Yayın Bilgisi 2010Kitap -
8
Generation of single-chain variable antibody fragments (scFv) against dengue virus by phage display
Baskı/Yayın Bilgisi 2002Tez -
9
-
10